has role piperidines secondary amine antineoplastic agent aromatic ether organobromine compound organofluorine compound quinazolines tyrosine kinase inhibitor vandetanib CHEBI:49960 A quinazoline that is 7-[(1-methylpiperidin-4-yl)methoxy]quinazoline bearing additional methoxy and 4-bromo-2-fluorophenylamino substituents at positions 6 and 4 respectively. Used for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease.